Alnylam to webcast conference call discussing third quarter 2024 financial results

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, announced today that it will report financial results for the third quarter ending september 30, 2024 on thursday, october 31, 2024, before the u.s. financial markets open. management will provide an update on the company and discuss third quarter 2024 results as well as expectations for the future via conference call on thursday, october 31, 2024 at 8:30 am et. a live audio w.
ALNY Ratings Summary
ALNY Quant Ranking